Nexus Surgical & Medicare
26.00
-2.03(-7.24%)
Market Cap₹14.19 Cr
PE Ratio19.47
Company Performance:
1D-7.24%
1M+40.62%
6M+45.99%
1Y+40.54%
5Y0.00%
View Company Insightsright
More news about Nexus Surgical & Medicare
14Feb 26
Nexus Surgical and Medicare Reports Strong Q3 FY26 Results with 49.76% Profit Growth
Nexus Surgical and Medicare Limited reported strong Q3 FY26 results with net profit of ₹17.01 lakhs, up 49.76% from ₹11.36 lakhs in Q3 FY25. Sales revenue nearly doubled to ₹293.08 lakhs, showing 97.55% growth year-on-year. Nine-month performance remained robust with net profit rising 21.29% to ₹49.62 lakhs and sales growing 37.34% to ₹582.19 lakhs. The company maintained stable capital structure and reported no investor complaints during the quarter.
 no imag found
03Jan 26
Nexus Surgical & Medicare Clarifies Recent Stock Price Movement to BSE
Nexus Surgical & Medicare Limited responded to BSE's surveillance inquiry about recent stock price movements, attributing the volatility to market conditions. The company confirmed compliance with SEBI LODR Regulations 2015 and stated no undisclosed price-sensitive information or pending announcements exist.
 no imag found
14Aug 25
Nexus Surgical & Medicare Reports 70% Jump in Q1 Profit, Revenue Dips Slightly
Nexus Surgical & Medicare Limited reported a significant increase in net profit for Q1 FY2024, rising 69.6% to ₹15.25 lakhs from ₹8.99 lakhs year-over-year. This growth came despite a 2% decrease in total income to ₹172.52 lakhs. The company effectively managed expenses, reducing them by 7.2% to ₹152.15 lakhs. Earnings per share improved by 75% to ₹0.28. Managing Director Ram Swaroop Joshi expressed satisfaction with the company's profitability improvement and efficient expense management.
 no imag found
Nexus Surgical & Medicare
26.00
-2.03
(-7.24%)
1 Year Returns:+40.54%
Industry Peers
Algoquant Fintech
64.22
(-0.08%)
Gyftr
185.08
(+2.69%)
Prime Securities
284.20
(-2.07%)
RNFI Services
300.10
(+0.12%)
Stellant Securities
1,054.95
(+1.44%)
Kalind
4.94
(+2.70%)